As announced yesterday afternoon, 60 Degrees Pharmaceuticals has priced its IPO at $5.30 per unit. The pricing was at the midpoint of the $4.30-$6.30 target range. WallachBeth Capital LLC is the Sole Bookrunner for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>